Associate Professor of Medicine, University Mich Medical School
Oncology
Dr. Susan G. Urba, MD
|
|
Give Review
Susan G. Urba practices Oncology. He studied medicine at University of Michigan Medical School. He over the years received 3 awards: "America's Top Doctors", "America's Top Doctors for Cancer" and "CMS Meaningful Use Stage 1 Certification". Susan Urba is a published doctor. He has 28 papers published. The most current publication "Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma." He is registered with Medicare.
Publications
- Efficacy of inDuction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
- A phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell Carcinoma of the head and neck (SCCHN): SWOG study S0329.
- Biomarkers in advanced larynx Cancer: Triological society thesis.
- Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal Cancer.
- Predictive factors in patients with advanced and metastatic squamous cell Carcinoma of the head and neck: A study based on SWOG protocol S0420.
- Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV positive and HPV negative locally advanced squ...
- Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal Cancer.
- Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck Cancer: Results of an explorato...
- Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck Cancer: Final results of a randomized, dou...
- Quality of life scores as prognostic factors of overall survival in advanced head and neck Cancer: Analysis of a phase III randomized trial of pemetrexed plus cisplati...
- Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell Carcinoma of the head and neck: Southwest Oncology ...
- Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
- Chemotherapy alone for organ preservation in advanced laryngeal Cancer.
- Phase II evaluation of sorafenib in advanced and metastatic squamous cell Carcinoma of the head and neck: Southwest Oncology Group Study S0420.
- Tobacco use in human papillomavirus-positive advanced oropharynx Cancer patients related to increased risk of distant metastases and tumor recurrence.
- Docetaxel, cisplatin, and fluorouracil inDuction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients wi...
- Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell Carcinoma with cartilage invasion.
- Advanced squamous cell Carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during indu...
- EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal Cancer.
- Chemoselection as a strategy for organ preservation in advanced oropharynx Cancer: response and survival positively associated with HPV16 copy number.
- Preoperative chemoradiation for the treatment of locoregional esophageal Cancer: the standard of care?
- Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck Cancer.
- Response to therapy and outcomes in oropharyngeal Cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and s...
- Phase II trial of erlotinib in gastroesophageal junction and gastric adenoCarcinomas: SWOG 0127.
- Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal Cancer.
- Organ preservation for advanced resectable Cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
- Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal Carcinoma.
Schools
University of Mi Med Sch
University Of Michigan
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Health Alliance
- Choice Care PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- PHP-Physicians Health Plan
- Priority PPO
- Sagamore Plus
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1447336318 | |
| NPPES Provider LastName | URBA | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 481095912 | |
| NPPES Provider State | MI | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 979.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 327.0 | |
| Percent Opioid Claims | 33.4 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447336318 |
| Last Name Of The Provider | URBA |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
|
Dr. Rashmi Chugh, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Todd M. Morgan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kunal C. Kadakia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Attaphol Pawarode, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip L. Palmbos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine H. Van Poznak, MD |
|
|
Dr. Jennifer J. Griggs, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alexander T. Pearson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick J. Hu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|